Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.4K
3.4K
Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Metastasis02:30

Metastasis

6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis02:30

Metastasis

3.8K
3.8K
Cancer02:18

Cancer

55.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes after pulmonary bilobectomy for NSCLC: The role of surgical type, indication, and pulmonary function.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

A single-center experience in parenchyma-sparing surgical treatment of malignant pleural mesothelioma.

Updates in surgery·2026
Same author

Mitomycin C in the Endoscopic Treatment of Airway Stenosis: A Systematic Review and a Meta-Analysis.

The Annals of otology, rhinology, and laryngology·2026
Same author

Identification of a Cut-Off Value to Identify Sarcopenia Through Pectoralis Muscle Area in Fibrotic ILDs: An International Study.

Archivos de bronconeumologia·2026
Same author

Biologic Therapy Timing and Severe Asthma Progression: Insights from the Italian Registry on Severe Asthma.

Respiration; international review of thoracic diseases·2026
Same author

Malignant Pleural Mesothelioma (MPM) Evaluation with [<sup>11</sup>C]-Methionine PET/CT Before and After Talc Pleurodesis.

Molecular imaging and biology·2026

Related Experiment Video

Updated: Mar 29, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Multiple primary synchronous malignant tumors.

Alberto Testori1, Ugo Cioffi2, Matilde De Simone3

  • 1Department of General and Thoracic Surgery, Humanitas Research Hospital, via Manzoni 56 Rozzano, 20089, Milan, Italy. alberto.testori@humanitas.it.

BMC Research Notes
|November 29, 2015
PubMed
Summary
This summary is machine-generated.

The incidence of multiple primary malignant tumors is rising, posing a diagnostic challenge. Early detection and individualized treatment are crucial for managing patients with synchronous cancers.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K

Related Experiment Videos

Last Updated: Mar 29, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K

Area of Science:

  • Oncology
  • Clinical Medicine

Background:

  • Increasing survival rates in cancer patients and advancements in diagnostics contribute to a rise in multiple primary malignancies.
  • Managing patients with multiple synchronous primary tumors presents unique clinical challenges.

Observation:

  • A case report details a 66-year-old Caucasian patient diagnosed with four synchronous primary malignant tumors.
  • The affected sites included the lung, oropharynx, large bowel, and prostate gland.

Findings:

  • The patient was managed with a multidisciplinary treatment approach tailored to their specific condition.
  • This case highlights the complexity of diagnosing and treating synchronous primary malignancies.

Implications:

  • Early and accurate diagnosis is essential to prevent misdiagnosis and ensure effective radical treatment for multiple cancers.
  • Treatment strategies for patients with multiple primary malignant tumors must be individualized and carefully considered.